Transcatheter prosthetic heart valve and delivery system

Information

  • Patent Grant
  • 12138160
  • Patent Number
    12,138,160
  • Date Filed
    Wednesday, January 11, 2023
    a year ago
  • Date Issued
    Tuesday, November 12, 2024
    10 days ago
Abstract
A method of implanting a prosthetic heart valve includes advancing a delivery catheter toward a native heart valve, wherein the delivery catheter has a distal capsule containing a prosthetic valve in a compressed state. The prosthetic valve includes a self-expandable interior stent and a self-expandable exterior wire mesh surrounding the interior stent. The exterior wire mesh preferably has a lower radial strength than the interior stent for conforming to a surrounding shape of the native valve. The prosthetic valve is expelled from the distal capsule and allowed to expand within the native valve. Capturing elements extending from a ventricular end of the interior stent trap native leaflets between the capturing elements and an outer surface of the wire mesh.
Description
FIELD OF THE INVENTION

The invention generally relates to devices for cardiovascular treatment. More specifically, the invention generally relates to devices for percutaneous heart valve replacement/implantation.


BACKGROUND OF THE INVENTION

Valvular heart disease is common and involves considerable mortality and morbidity. Surgical replacement of the failing valve is the treatment of choice when the disease progresses and certain criteria are fulfilled. However, it is not uncommon patients fulfilling the criteria for this treatment to be rejected due to a perceived unacceptably high surgical risk for a variety of reasons such as advanced age and comorbidities. For some it is their decision to deny this treatment. These factors drove the development of prosthetic heart valve devices that can be implanted percutaneously with guiding catheters. Many such devices for the treatment of aortic valve stenosis have gained regulatory approvals and are already successfully and widely used offering clinical and survival benefits in many patients. Recently, we have seen the first device gaining regulatory approval for the percutaneous treatment of aortic valve insufficiency.


Aortic and mitral valve disease (stenosis and/or insufficiency) are equally common but despite the success in developing percutaneous prosthetic valves for the aortic valve, developing a device for percutaneously replacing the mitral valve have been challenging and problematic. The main reason is the much more complex and uneven anatomy of the mitral valve.


Apparently, the development of such a device for the percutaneous replacement of the mitral valve would be of great benefit for many patients.


This invention provides numerous alternative solutions to overcome these problems and develop a successful percutaneously delivered prosthetic mitral valve. Some of the solutions described could be used for similar prosthetic devices for implantation in other heart valves.


SUMMARY OF THE INVENTION

The invention relates to a prosthetic heart valve for an endoprosthesis used in the treatment of a stenotic heart valve and/or a heart valve insufficiency. The prosthetic heart valve comprises a plurality of leaflets, which consist of a natural and/or synthetic material and are being able to switch between their open and close position in response to the blood flow through the heart. The leaflets are attached into a collapsible wire valve frame involving a stent part and a wire mesh part that complement each other in many ways. The frame has a body that defines a lumen to its inside. The exterior portion of the frame has features that serve for its conformation and stabilization/anchoring in the anatomic structures it contacts. When the endoprosthesis apparatus is expanded within the intended failing native heart valve it replaces it and resumes its function.


The endoprosthesis is contained in a sheathed capsule and is inserted into the body and advanced to the intended location with a delivery system for percutaneously deploying a prosthetic heart valve. This system apart from the sheathed capsule includes an inner shaft assembly, and a handle maintaining control knobs that enable independent movement of the various parts of the sheathed capsule and the endoprosthesis. The handle functions allow for gradual release and deployment of the endoprosthesis, but also can recapture the endoprosthesis and safely remove it out of the body even after its complete deployment to its full functional status.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows a first embodiment of a prosthetic valve according to the present invention.



FIG. 2 shows a further embodiment of a prosthetic valve according to the present invention.



FIG. 3 shows one way of releasing a prosthetic valve according to the invention from its capsule.



FIG. 4 shows another embodiment of a prosthetic valve according to the present invention.



FIG. 5 shows another embodiment of a prosthetic valve according to the present invention.



FIG. 6 shows another embodiment of a prosthetic valve according to the present invention.



FIG. 7 shows another embodiment of a prosthetic valve according to the present invention.



FIG. 8 shows another embodiment of a prosthetic valve according to the present invention.



FIG. 9 shows the positioning of a prosthetic valve according to the present invention in a patient's heart.



FIG. 10 shows an embodiment of a catheter for the delivery of a prosthetic valve according to the present invention.



FIG. 11 shows the initial part of a transapical deployment of a prosthetic valve according to the present invention.



FIG. 12 shows a transapically deployed prosthetic valve according to the present invention.



FIG. 13 shows a further embodiment of a catheter for the delivery of a prosthetic valve according to the present invention.



FIG. 14 shows one way of releasing a prosthetic valve according to the invention from its capsule.



FIG. 15 shows the initial part of a transatrial/transeptal deployment of a prosthetic valve according to the present invention.



FIG. 16 shows a transatrially/transeptally deployed prosthetic valve according to the present invention.





DETAILED DESCRIPTION OF THE INVENTION

Transcatheter Mitral Valve


This prosthetic heart valve and its delivery system are intended for use in the treatment of mitral valve insufficiency and/or mitral valve stenosis. The delivery method is retrograde (the approach of the diseased mitral valve is achieved from within the left ventricle-transapical access and against the flow of the blood) or antegrade (the approach of the diseased mitral valve is achieved from within the left atrium after direct surgical approach or transeptal puncture and along with the flow of the blood), with the use of specifically designed for each access delivery systems.


The endoprosthesis comprises of a plurality of leaflets attached to a collapsible wire frame. This frame integrates a stent part and a braided and/or flat wire mesh part that complement each other in many ways. The combination of these two different resources in building the frame of the transcatheter valves described in this invention is very important and it is believed to solve many of the problems encountered to date for the development of a successful percutaneous prosthetic mitral valve. The stent part towards its ventricular end and the wire mesh part towards its atrial end. The wire mesh surrounds the stent at the atrial end and forms a body around the stent extending beyond the atrial end. According to certain embodiments of the present invention, the wire mesh extends also longitudinally towards the ventricular end of the stent forming again a body around the stent. There are limitless combinations of the relative length proportions of the endoprosthesis these parts may occupy, and they may overlap. It can have several standardized shapes and sizes. It can even be custom made based on measurements from the patient's anatomy obtained by medical imaging.


The outer parts of the wire mesh towards the atrium may be braided or flat. The rest of the wire mesh is braided. The stent part that will cover at least the annulus level has a sealing skirt from suitable material. The stent part may be cylindrical or conical (and may have a flaring towards the ventricle in order to withstand the excessive systolic forces exerted on the device with every heart beat). The wire mesh part can incorporate a fabric or other sealing material to make it instantly impermeable.


The stent part may be made of collapsible nitinol, stainless steel or other material and can self-expand. The wire mesh may be made of collapsible nitinol, stainless steel or other material and can self-expand. The advantages of the stent component is that it has maximal radial force and thus can appose and stabilize the frame optimally in areas of the mitral valve this is needed (such as the annulus area). It also provides the areas at which the prosthetic valve leaflets are attached and other structures described later. The wire mesh on the other hand, can better conform and adapt to areas of uneven and unpredictable anatomy and offer optimal sealing of unwanted blood flow by doing so. The shutting of unwanted blood flow can be instant when fabric or other components are incorporated into or on the mesh. The flat wire mesh can expand to larger diameters and reach longer where needed without occupying large volumes. The braided wire mesh may expand less but it self-adjusts perfectly to fill in restrained spaces (such as spaces between the mitral valve annulus and the stent part of the frame) and to assume the shape of the anatomy it apposes to (such as the mitral valve annulus).


The endoprosthesis frame apposes to the intended area and its anatomically designed shape together with its radial strength and its other supporting features allow it to steadily fix. In addition, the frame has particular features on its outer surface that allow deploying the endoprosthesis at the anatomically appropriate area. The frame also allows for degrees of auto-adjustment towards the anatomically appropriate area/plane. Besides the integration of a stent and a wire mesh to form the frame of the endoprosthesis, the second most important feature in the invented solutions presented in the following sections is the provision of particular components of the stent to guide and retain the device to the anatomically correct deployment position by tracking these components behind the native mitral valve leaflets and capturing them wide-open (FIG. 2, 9). These components are referred to as capturing elements. According to a preferred embodiment of the present invention, the capturing elements comprise a part that extends radially beyond the body of the wire mesh which surrounds the stent.


The valve leaflets can consist of a natural and/or synthetic material and are being able to switch between their open and close position in response to the blood flow through the mitral valve. Their fixed sides are seamed or attached with other means at the wire frame of the endoprosthesis (such as the stent ring end and the interior native valve leaflet enveloping elements). They start to function when the wire mesh part of the endoprosthesis is released.


The delivery catheter comprises a distal capsule that contains the endoprosthesis at its compressed state and the catheter shaft assembly that extends from within the capsule to the outer system handle. The handle maintains control knobs and/or dials and/or buttons that are connected to layers of the shaft assembly that on their other end within the capsule function to gradually open the capsule and uncover the endoprosthesis. This causes the uncovered parts of the latter to assume their default-uncompressed state and shape, allowing the inner lumen of the frame to form and the valve leaflets to commence function propelled by the blood flow. The handle also maintains functions that allow through shaft layers and or other components to resheath and remove the endoprosthesis even after full delivery and function is achieved.


The device allows for complete atraumatic re-capture/research and removal of the endoprosthesis even after its full deployment and assumption of its function.


DETAILED DESCRIPTION OF THE EMBODIMENTS
Embodiment 1


FIG. 1 shows a first embodiment of a prosthetic mitral valve according to the present invention comprising a stent (1) and a wire mesh (2) surrounding the stent at the atrial end and forming a body around the stent (2) which extends beyond the atrial end. The stent comprises internally three valve leaflets (3, 4, 5). Furthermore, the stent forms at its ventricular end a pair of capturing elements (6) which capture the native leaflets thus providing positioning guidance and anchoring/retention.


Embodiment 2

The endoprosthesis (FIG. 2) comprises of a plurality of leaflets, which consist of a natural and/or synthetic material and are being able to switch between their open and close position in response to the blood flow through the heart. The leaflets are attached into a collapsible wire valve frame that includes a stent (7) and a wire mesh (8). The frame has a body that defines a lumen to its inside. The exterior portion of the frame has features that serve for its conformation and stabilization/anchoring in the anatomic structures it contacts. When the endoprosthesis apparatus is expanded within the intended failing native heart valve it replaces it and resumes its function. The frame of the endoprosthesis includes a stent and a wire mesh. All these are also described in the embodiment 1.


The stent part of the endoprosthesis includes a crown (9), and a ring (10). The crown includes capturing elements for each of the native valve leaflets (11). Each such element has an exterior (12) and an interior part (13) for enveloping/capturing/clipping the respective native valve leaflet. The first component of the stent that expands within the left ventricle is the part of the crown that has at least two external wings/hooks/clipping elements (14), also shown in FIG. 3A, 3B, which are the first to appear when the ventricular part of the capsule starts to open towards the apex of the ventricle. Once released, they are fully expanded. Their expansion (“opening”) is achieved by the default design of the frame as they exit the sheath and possibly from special features at their articulation to the rest of the frame (such as thicker areas of the struts close to the articulation that push away the external elements when released, but as the frame opens these areas do not overlap anymore and the external elements come close again to their internal counterparts to clip the leaflets).


These external elements when released are aligned using continuous real-time imaging modalities, such as transesophageal echocardiography, to extend behind (outside) each of the two native mitral valve leaflets. At the same time the tips of the interior enveloping/capturing/clipping elements start to flare (15) when the ventricular side of the capsule opens to fully release their outer counterparts. Once this is achieved the entire system is moved so that the tips of the exterior wings/hooks/clipping elements approach and contact the mitral valve annulus at its ventricular side. It is expected that when this occurs the operator will experience resistance providing tactile feedback for the correct positioning. During this initial phase the native mitral valve function is uninterrupted. The exterior elements by sitting behind the leaflets and reaching deep into the annulus create an anchoring of the entire frame on the ventricular side of the mitral annulus.


Then, and while exerting a steady force to keep the external wings/hooks/clipping parts at or as close as possible to the ventricular side of the mitral annulus, the atrial side of the capsule opens releasing the rest of the endoprosthesis frame.


The first to be released next is the part of the stent crown that holds the bases of the internal enveloping/capturing/clipping elements. These expand towards their external counterparts and capture/envelop/clip the native valve leaflets locking them into a wide-open position by doing so. By pairing these hooking components on either side of the native valve leaflets these are engulfed/enveloped/clipped in between them and as the frame keeps expanding they are locked in this position. The interior pairing constituents (13) have sufficient length to capture at least the tips of the native leaflets before they join the stent ring. They may also be made to have a progressively greater default expansion towards the annulus (16) than their exterior counterparts, and by doing so they fix the native valve leaflets actively inside (essentially by clipping them). The pairing components can have a range of shapes that pinch the native leaflets in between (12, 13). Furthermore, the capture elements of the anterior and posterior native valve leaflets may differ in shape to match the different anatomy of these leaflets. For example, the exterior elements of the anterior leaflet may be wider and longer than their interior counterparts and have a reversed M shape so that their two bases are seated closer to the fibrous trigones on both sides of the anterior leaflets (FIG. 2A).


After the stent crown is released and the native valve leaflets are locked wide open in it, the ring of the stent is released. The stent ring has a fabric skirt layer attached for sealing the areas of the annulus it apposes to from unwanted blood flow. The shape of the ring may be rather oval and in any case resembling and conforming optimally with the shape of the mitral valve annulus. Externally it may have anchoring elements such as hooks, barbs, spikes, indentations or similar (17) to secure on the annulus as it apposes against it, and provide additional stabilization of the endoprosthesis at the annulus on this occasion. These anchoring features are mainly found towards the perimeter of the stent that apposes to the commissural areas of the annulus. Maximal radial strength is given at the larger diameter of the stent. The radial strength of the stent arc that apposes the annulus at the root of the anterior leaflet is calculated so that it does not push the leaflet into the outflow tract of the left ventricle and cause obstruction. For the same reason, the clipping mechanism of the anterior leaflet when fully expanded may have an incline away from the outflow tract.


In the interior part of the stent ring there are elements for passively attaching the endoprosthesis on its delivery catheter pins during the crimping process. This passive attachment offers stabilization of the endoprosthesis on its delivery catheter while the capsule components move to release various parts of it, till of course the capsule uncovers the area of the stent ring that sits on the catheter pins and releases it.


The prosthetic valve leaflets are attached to the stent ring and the interior enveloping elements of the stent crown but can also be attached at other purposely-devoted posts of the stent (FIG. 2C).


Lastly, the wire mesh part of the endoprosthesis (8) is released by continued opening of the atrial side of the capsule (FIG. 3C, 3D). This consists of a rather oval shaped (that in any case resembles the anatomy of the annulus) thin wire mesh that can incorporate a fabric or other material to make it instantly impermeable. It is attached and is the continuation of the most atrial side of the stent. When released, it expands from the native valve annulus overlapping with the stent towards the surrounding atrial walls. It has sufficient length to extent enough into the atrial side of the mitral valve annulus. By doing so stabilizes the endoprosthesis at the atrial level of the annulus and allows auto-adjustment of the entire endoprosthesis. It has a progressively larger default diameter than the atrial side of the stent, and it may be made to have a tendency to revert backwards and appose actively to the atrial wall on the atrial side of the annulus and above it offering superior sealing from paravalvular insufficiency and improving the stabilization of the entire frame. The length of the wire mesh ring can differ locally to conform best to the anatomy it apposes to. The entire mesh wire can be braided. Alternatively, the most exterior parts of the wire mesh that are away from the annulus can be made of flat mesh, while as it comes closer to the annulus it becomes braided.


In summary, all segments offer the stabilizing mechanism of this endoprosthesis. The stent crown of the frame contains the paired elements that actively capture, envelope and lock wide open the two native valve leaflets. In addition, the bases of the exterior elements are behind the native leaflets and are immobilized by the ventricular side of the annulus. This latter segment offers also tactile feedback for the correct positioning of the endoprosthesis.


The stent ring expands and apposes the native valve annulus and has also special features for anchoring on it. Finally, the wire mesh offers stabilization at the level of the annulus and towards the atrial side and locks the endoprosthesis at its final position, offering at the same time room for self-adjustment and self-alignment.


The release of this endoprosthesis starts from the ventricle and ends in the left atrium.


The endoprosthesis can have several standardized shapes and sizes. It can even be custom made based on measurements from the patient's anatomy obtained by medical imaging.


The resheath/recapture/removal capability of the endoprosthesis, even after complete deployment, is described in the delivery catheter section.


Embodiment 3

Another version (FIG. 4A) of the described in the embodiment 2 endoprosthesis can be deployed in the opposite way, starting from the atrial side (FIG. 4B, 4C, 4D). First, the wire mesh is gradually released within the left atrium (FIG. 4B, 4C). The valve then is pulled downward till the wire mesh seats firmly at the floor of the atrium. Then the stent ring (18) is released followed by its crown (19) that contains a plurality of anchoring structures (hooks, barbs, spikes, indentations or similar) (20) extending into the ventricular side of the annulus. Two of them may be seated and capture the fibrous trigones on both sides of the anterior leaflet and hold this leaflet wide-open. Another component of the crown may extend in the middle part of the posterior leaflet (21). This is longer and therefore the last to be completely released from the delivery system. Its final part folds completely backwards (22) towards the ventricular side of the annulus to capture the posterior leaflet.


The elements for passively attaching of this endoprosthesis on its delivery catheter pins during the crimping process are at the most ventricular tips of the stent crown. This is the part of the endoprosthesis released last. This passive attachment offers steadiness of the endoprosthesis on its delivery catheter while the capsule components move to release various parts of it, till of course the capsule uncovers this final part.


The endoprosthesis can have several standardized shapes and sizes. It can even be custom made based on measurements from the patient's anatomy obtained by medical imaging. The prosthetic valve leaflets are attached to the stent ring and the interior enveloping elements of the stent crown but can also be attached at other areas of the wire frame.


Embodiments 4 a,b

Another version of either of the two previous embodiments (2 and 3) can have a more dominant wire mesh part that alone or with a degree of overlap with the stent part apposes at the annulus and succeeds the stabilization of this endoprosthesis (FIG. 5). In the previous two versions it was mainly the stent ring of the frame to be apposed and seated at the annulus level. In this version the wire mesh (23) occupies a larger length of the frame of the endoprosthesis and allows it to well reach and appose in the annulus. The stent part (24) is mostly below the annulus (FIG. 5A, 5B) but may also reach the level of the annulus and overlap internally the wire mesh (FIG. 5C).


The wire mesh of this endoprosthesis covers from just below the annulus, then covers it and extends at the surrounding atrial walls. It has a trench or channel or concavity at its outer perimeter (25) that has the shape of the annulus and slightly oversizes it, so that by expanding on the annulus sits on its both sides fixing perfectly and steadily the endoprosthesis.


The stent part in this case, connects to the wire mesh below the annulus and it is shorter. Alternatively, it may have a component to surround the wire mesh away from its outer perimeter (internally) at the level of the annulus and provide additional radial force to it (FIG. 5C). Then it has a crown part extending towards the left ventricle (26) with elements to hold or capture the native valve leaflets wide open. The stent crown can be similar to embodiment 2, and in this case the ventricular part of the endoprosthesis is first deployed allowing for capturing the native valve leaflets, self-positioning below the annulus and anchoring and stabilization at the ventricular side. Then the rest of the stent and the wire mesh are deployed (embodiment 4a) (FIG. 5A).


The stent crown can also be similar to embodiment 3, and in this case the atrial part of the endoprosthesis is first deployed and pulled downward till the wire mesh seats firmly at the floor of the atrium. Then the rest of the wire mesh is deployed surrounding the annulus and finally the stent parts that hold or capture the native valve leaflets wide-open and offer additional anchoring and stabilization at the ventricular side (embodiment 4b) (FIG. 5B).


The wire mesh incorporates a fabric or other material to make it instantly impermeable and may have a fabric skirt at the level of the annulus for better sealing. The endoprosthesis can have several standardized shapes and sizes. It can even be custom made based on measurements from the patient's anatomy obtained by medical imaging.


The prosthetic valve leaflets are attached to the wire frame of the endoprosthesis at the stent part.


Embodiment 5

This version is similar to the previous embodiment 4, but the frame of this endoprosthesis is entirely formed by the wire mesh (FIG. 6).


The atrial side is first released within the left atrium. The valve then is pulled downward till the wire mesh seats firmly at the floor of the atrium. By doing so stabilizes the endoprosthesis at the atrial level of the annulus and allows auto-adjustment of the entire endoprosthesis. It has a progressively larger default diameter at its atrial side, and it may be made to have a tendency to revert backwards and appose actively to the atrial wall on the atrial side of the annulus and above it offering superior sealing from paravalvular insufficiency and improving the stabilization of the entire frame. The dimensions of the wire mesh can differ locally to conform best to the anatomy it apposes to. The entire mesh wire can be braided. Alternatively, the most exterior parts of the wire mesh that are away from the annulus can be made of flat mesh, while as it comes closer to the annulus it becomes braided. The wire mesh incorporates a fabric or other material to make it instantly impermeable. It can also have a fabric skirt at the level of the annulus for better sealing.


Then by keeping the opened atrial part on the floor of the atrium the part that apposes at the annulus is released. This has a trench or channel or concavity at its outer perimeter that has the shape of the annulus and slightly oversizes it, so that by expanding on the annulus it sits on its both sides fixing perfectly and steadily the endoprosthesis.


The wire mesh extends more into the surrounding atrial walls than in the ventricular side of the annulus (FIG. 6A). The shape and dimensions of the atrial and ventricular parts of the mesh are such to appose comfortably at their intended locations.


This endoprosthesis wire mesh frame may have one or more of the additional components: A. A collapsible wire component, such a short stent, to surround the wire mesh internally at the level of the annulus and to provide additional radial force to it at that level (27). B. Stand-alone or connected wire elements (hooks, barbs, spikes, indentations or similar) at the outer ventricular surface of the frame for anchoring below the annulus (28). C. Particular wire posts and elements for attachment of the prosthetic leaflets and for holding the native valve leaflets wide open (29).


The wire mesh incorporates a fabric or other material to make it instantly impermeable and may have a fabric skirt at the level of the annulus for better sealing. The endoprosthesis can have several standardized shapes and sizes. It can even be custom made based on measurements from the patient's anatomy obtained by medical imaging.


The prosthetic valve leaflets are attached to the wire frame of the endoprosthesis. This endoprosthesis can be deployed either from its atrial or its ventricular side.


Embodiment 6

This embodiment describes an endoprosthesis, which is a version of either the embodiments 2-4 endoprosthesis. The main feature of this version that makes it distinct from those embodiments is that the stent part of the endoprosthesis frame is dominant and occupies the majority or the entire length of the frame, with the wire mesh part being exterior to it forming a body around it (FIG. 7A). The lumen of the endoprosthesis is therefore defined completely by the stent, which is fully surrounded by the wire mesh.


The wire mesh (30) default shape and dimensions are to out-expand the mitral valve annulus towards the atrium to allow the seating, sealing and stabilization of the endoprosthesis at its atrial side. Then the wire mesh continues as a band surrounding the stent at the annulus area and may reach just below it. This part of the wire mesh seals the endoprosthesis at the annular level. It allows the stent to appose within it and compresses on the surrounding tissues offering an optimal adaptation and stabilization at this level.


The dominant stent part in this embodiment takes advantage of the greater radial strength the stent provides to the entire frame and it allows for the formation of a uniform and assured lumien throughout the frame. The skirted stent reaches below the annulus but is short of the tips of the leaflets and its surrounding wire mesh seals any anatomical asymmetries.


The ventricular end of the stent comprises capturing elements (31) that offer stabilization of the endoprosthesis at the ventricular side and holding and capturing the native valve leaflets wide open.


In case the crown of this endoprosthesis is similar to embodiments 2 or 4a, the endoprosthesis is guided and navigated through the ventricle to capture/envelope the native mitral valve leaflets and then the rest of the endoprosthesis is expanded towards the atrium (embodiment 6a) (FIG. 7A).


In case the crown of this endoprosthesis is similar to embodiment 3 or 4b, the endoprosthesis is deployed from the atrium down to the lest ventricle, expanding the crown elements that trap the native mitral leaflets wide open and offer anchoring on the ventricular side of the annulus (embodiment 6b) (FIG. 7B).


The wire mesh incorporates a fabric or other material to make it instantly impermeable and may have a fabric skirt at the level of the annulus for better sealing. The stent part that is not covered by the mesh wire is skirted with a material so blocking any blood flow through its cells/struts. The endoprosthesis can have several standardized shapes and sizes. It can even be custom made based on measurements from the patient's anatomy obtained by medical imaging.


The prosthetic valve leaflets are attached to the stent of the endoprosthesis.


This endoprosthesis can be deployed either from its ventricular (embodiment 6a) or its atrial side (embodiment 6b).


Embodiment 7

This embodiment describes an endoprosthesis, which is a version of the embodiment 6 endoprosthesis. The main feature of this version that makes it distinct is that the interior capturing elements of the native mitral valve leaflets is the stent ring itself rather than parts of its crown (FIG. 8, FIG. 9A).


The crown of the stent comprising the exterior capturing elements (32) that provide navigational guidance for the positioning and the stabilization of the endoprosthesis at the ventricular side of the mitral valve annulus (first step of deployment). They expand outside of the native leaflets and as the endoprosthesis is pushed upwards and towards the annulus they are captured by these elements. Then, by continuing the delivery of the endoprosthesis the next part of it expanding is the stent ring itself (33) that apposes against the leaflets from their interior surface. When this occurs the native valve leaflets are captured between the stent and the its external capturing elements. Then the rest of the endoprosthesis is released. This has a thin wire mesh band expanding at the level of the annulus. The wire mesh then outexpands the annulus at its atrial side offering sealing and stabilization. The most ventricular end of the stent may be wire mesh-free (FIG. 8, FIG. 9B).


The endoprosthesis described is deployed from its ventricular side upwards and towards the atrium (embodiment 7a).


To avoid possible prolapse of the stent into the outflow of the left ventricle, a shorter part of the stent crown and its interior capturing elements (as described in endoprosthesis 6) may be preserved especially in the arc of the annulus that apposes towards the native anterior mitral leaflet (34).


In case the crown of this endoprosthesis is similar to embodiment 3, the endoprosthesis is deployed from the atrium down to the lest ventricle, expanding the crown elements that trap the native mitral leaflets wide open and offer anchoring on the ventricular side of the annulus (embodiment 7b).


The wire mesh incorporates a fabric or other material to make it instantly impermeable and may have a fabric skirt at the level of the annulus for better sealing. The stent part that is not covered by the mesh wire is skirted with a material so blocking any blood flow through its cells/struts.


The endoprosthesis can have several standardized shapes and sizes. It can even be custom made based on measurements from the patient's anatomy obtained by medical imaging.


The prosthetic valve leaflets are attached to the stent of the endoprosthesis.


This endoprosthesis can be deployed either from its ventricular side as described (embodiment 7a) or its atrial side (embodiment 7b).


The Delivery Catheter


1. Retrograde Access (Transventricular/Transapical)


The delivery catheter for the endoprosthesis of all embodiments consists of the capsule (FIG. 10,35) that contains the collapsed endoprosthesis, the shaft (36) and the handle (37). They all share a central lumen (38) that accommodates the guide wire over which the device is railed at the intended position of deployment.


The capsule contains the crimped endoprosthesis. Both of its ends are conical (39) to allow smooth tracking.


For the endoprosthesis of the embodiments 1, 2 and 4a the capsule opens in two parts (FIG. 3, FIG. 10) the atrial part that is longer (40) and the ventricular part that is shorter (41). Each of these parts can move and open/close the respective part of the capsule independently. First the ventricular part is opened (withdrawn/pulled back) the part of the endoprosthesis crimped in this part expands (FIG. 3A, 3B), namely the outside capturing elements of the native valve leaflet expand fully, while their internal counterparts start to flare. When the external capturing/anchoring components are positioned deep behind the native leaflets and if possible in contact to the ventricular side of the annulus, the atrial part of the capsule is opened (advanced/pushed) releasing gradually first the internal native leaflet capturing elements, and then the stent ring and the wire mesh that appose to the annulus and towards the surrounding atrial wall (FIG. 3C, 3D).


When the endoprosthesis is fully deployed and functional it is still connected to the delivery catheter with a plurality of thin wires (such as ultra thin nitinol wires) (42), or screwing wires attached at the most ventricular edge of the stent (area connecting the external and internal capturing elements). Therefore complete atraumatic removal of the endoprosthesis is still feasible. When thin wires are used, they are threaded trough the stent. If the endoprosthesis position and function is satisfactory, one end of the thin wire is pulled till the entire thread is removed from the endoprosthesis and releases it. If the endoprosthesis needs to be removed both ends of the thin wires are pulled together. Another way of reversible connection of the thin wires to the stent is with Highwayman's knots, that allow tightening the knot and tugging by pulling one end of the wire, while the knot unties easily by pulling the other end of the wire.


Finally, an alternative way of attachment is by use of screwing wires that are fixed in female parts found at the stent end.


The part of the shaft traveling inside through the capsule has an inner hollow to accommodate the guide wire (38). The shaft of this lumen allows the push and opening of the atrial segment of the capsule. An additional shaft layer travels the capsule and the endoprosthesis is crimped on it. This layer has a plurality of pins at the level of the stent ring (43) on which the stent is passively stabilized by mirroring elements at its exterior surface.


The ventricular segment of the capsule is connected to an additional shaft layer (44) that is found on the delivery system (not in the capsule). A part of this layer starting at the capsule and having sufficient length can effortlessly expand to accommodate a part of the endoprosthesis in case it needs to be removed after complete deployment. This is required because the ventricular segment of the capsule is smaller and cannot accommodate the entire length of the collapsing stent and wire mesh. The entire length of the endoprosthesis needs to be sheathed in order the atrial capsule part to come close, meet and attach its ventricular part and the entire capsule safely removed.


When the delivery is considered successful and the holding wires are removed, the empty atrial capsule segment is withdrawn to meet and attach to the also empty ventricular capsule segment and then the capsule is closed and removed in one piece (FIG. 3D).


The shaft of the delivery system that connects the capsule to the handle has the previously described layers plus a space (could be in the form of an additional lumen) to accommodate the retracting holding wires of the endoprosthesis (45).


The handle is where all the above-described components of the shaft culminate. It has a central lumen for the guide wire to exit (46) and all the necessary knobs/dials/wheels (47) to facilitate the independent motions of the two capsule segments, and the thin wires that are used to resheath and remove the valve if needed. It is envisaged that one knob/dial/wheel is required for the movement of the atrial capsule, one for the movement of the ventricular capsule and possibly one for the pulling of the holding wires.


The delivery catheter is advanced in the left ventricle by itself or through a guide sheath. The guide sheath and/or the delivery catheter can have flexing capabilities to assist the coaxial and central to the annulus positioning of the capsule before and during delivery.


Considering the endoprostheses of the embodiments 3, 4b and 5 the delivery catheter is similar, but the capsule does not split into two parts, and it opens from its atrial tip towards the ventricle (the endoprosthesis of the embodiment 1 can also be released such a way) (FIG. 4B, 4C, 4D). First, the wire mesh is released completely within the atrium. The entire device then is pulled downward till the wire mesh seats firmly at the floor of the atrium. Then the capsule is further withdrawn releasing gradually the wire frame that apposes to the annulus and the crown components of the stent part in embodiments 3 and 4b or the ventricular part of the wire mesh in the embodiment 5.


The wire frame of the endoprosthesis and the course of the anchoring structures allow for complete retrieval of the endoprosthesis even after complete release.


The unnecessary parts of the delivery catheter for delivering this endoprosthesis are omitted (such as the separate shaft layer for the stabilization pins of the endoprosthesis and the handle wheel for moving the atrial segment of the capsule). A plurality of holding wires for retrieval of the endoprosthesis is reversibly attached (as described before) at the tips of the anchoring or other structures of the stent crown. By pulling these, the endoprosthesis reenters into the delivery capsule.



FIGS. 11 and 12 illustrate an example of transapical delivery of one of the embodiments described.


2. Antegrade Access (Transeptal, or Direct Approach)


The delivery catheter for the endoprosthesis of all embodiments consists of the endoprosthesis capsule, the shaft and the handle (FIG. 13). They all share a central lumen that accommodates the guide wire over which the device is railed at the intended position of deployment.


The capsule contains the collapsed and crimped endoprosthesis. Its both ends are conical to allow smooth tracking forward and backward.


For the endoprosthesis of the embodiments 1, 2 and 4a the capsule opens in two parts, the atrial part is longer and the ventricular part is shorter (FIG. 14). Each of these parts can move and open/close the respective part of the capsule independently. First the ventricular part is opened (advanced/pushed) and the part of the endoprosthesis crimped in this part expands, namely the external capturing elements of the native valve leaflets expand fully, while their internal counterparts start to flare. When the external capturing elements are positioned deep behind the native leaflets and in contact to the ventricular side of the annulus, the atrial part of the capsule is opened (withdrawn/pulled back) releasing gradually first the internal capturing elements of the stent crown, then the stent ring and finally the wired mesh. When the endoprosthesis is fully deployed and functional it is still connected to the delivery catheter with a plurality of thin wires (such as ultra thin nitinol wires) or screwing wires attached at the most atrial edges of the wire mesh. Therefore complete atraumatic removal of the endoprosthesis is still feasible. When thin wires are used, they are threaded trough suitable features of the wire mesh. If the endoprosthesis position and function is satisfactory, one end is pulled till the entire thread is removed from the endoprosthesis and releases it. If the endoprosthesis needs to be removed both ends of the nitinol wires are pulled, and it is gradually retracted into the atrial capsule. Another way of reversible connection of the thin wires to the mesh is with the Highwayman's knot that allows tightening the knot and tugging by pulling one end of the wire, while the knot unties easily by pulling the other end of the wire.


Finally, an alternative way of attachment is by use of screwing wires that are fixed in female parts in the mesh.


The part of the shaft traveling inside through the capsule has an inner lumen to accommodate the guide wire. The shaft of this lumen allows the push and opening of the ventricular segment of the capsule. An additional shaft layer travels the capsule and the endoprosthesis is crimped on it. This layer has a plurality of pins at the level of the stent ring on which the stent is passively stabilized by mirroring elements at its exterior surface.


The atrial segment of the capsule is connected to an additional shaft layer that is found on the delivery system (not in the capsule). This withdraws the atrial segment of the capsule, to completely release the endoprosthesis.


A part of this layer starting at the capsule and having sufficient length can effortlessly expand to accommodate a part of the endoprosthesis in case this needs to be removed after complete deployment. This is required because the entire length of the endoprosthesis needs to be sheathed into the atrial segment of the capsule. This additional space is required for the length of the stent that used to be accommodated into the ventricular capsule. The entire length of the endoprosthesis needs to be sheathed into the atrial capsule for the ventricular capsule segment to attach and close the capsule for safe removal.


If the deployment is not satisfactory, the wire mesh is first resheathed into the longer atrial capsule. The small part of the endoprosthesis that used to be accommodated into the ventricular capsule is also retracted into the atrial capsule, as described. When the delivery is considered successful and the holding wires are removed, the empty ventricular capsule segment is withdrawn to meet and attach to the also empty atrial capsule segment and they are then removed en block.


The shaft of the delivery system that connects the capsule to the handle has the previously described layers plus a space (could be in the form of an additional lumen) to accommodate the holding/retracting wires of the endoprosthesis.


The handle is where all the above-described components of the shaft culminate. It has a central lumen for the guiding wire to exit and all the necessary knobs/dials to facilitate the independent motions of the two capsule segments, and the wires that can be used to resheath and remove the valve if needed. It is envisaged that one knob/dial is required for the movement of the atrial capsule, one for the movement of the ventricular capsule and possibly one for the pulling of the holding wires.


The delivery catheter is advanced in the left atrium through a transeptal sheath or with direct access. The transeptal sheath and/or the delivery catheter can have flexing capabilities to assist the coaxial and central to the annulus positioning of the capsule before and during delivery.


Considering the endoprostheses of the embodiments 3, 4b and 5, the delivery catheter is similar, but the capsule does not split into two parts, and it opens from its atrial tip towards the ventricle (the endoprosthesis of the embodiment 1 can also be released such a way) (FIG. 4B, 4C, 4D). First, the wire mesh is released completely within the atrium by advancing the capsule towards the ventricle. The entire device then is pushed downward till the wire mesh seats firmly at the floor of the atrium. Then the capsule is further advanced releasing gradually the rest of the wire frame that apposes to the annulus and the crown components of the stent part in embodiments 3 and 4 or the ventricular part of the wire mesh in the embodiment 5.


The wire frame of the endoprosthesis and the course of the anchoring structures allow for complete retrieval of the endoprosthesis even after complete release.


A plurality of holding wires for retrieval of the endoprosthesis is reversibly attached (as described before) at the atrial edges of the wire mesh. By pulling these, the endoprosthesis reenters into the atrial segment of the delivery capsule.



FIGS. 15 and 16 illustrate an example of transapical delivery of one of the embodiments described.


In summary, the claimed inventions provide for all aspects of a successful transcatheter prosthetic mitral valve. They resolve the problems related to the uneven anatomy of the mitral valve by offering remedies at the level of the mitral valve leaflets (capture in a wide-open position and stabilization at the ventricular side), at the level of the annulus (optimal apposition, sealing and stabilization by the prosthetic valve frame) and at the level of the atrial floor (optimal apposition, sealing and stabilization by the prosthetic valve frame).


These are achieved with: 1. A refined combination of two components in the frame of the endoprosthesis, namely the wire stent contributing optimal radial strength for the formation of the frame lumen and the orifice of the prosthetic valve and the wire mesh contributing plasticity and optimal conformation. 2. An innovative method to capture and immobilize the native valve leaflets and navigationally guides the deployment of the prosthetic valve offering tactile feedback and at the same time the much-required stabilization at the ventricular level.

Claims
  • 1. A method of implanting a prosthetic mitral valve in a native mitral valve, comprising: advancing a delivery catheter through an atrial septum in a human heart and toward a native mitral valve, the delivery catheter having a distal capsule containing a prosthetic mitral valve in a compressed state, the prosthetic mitral valve including: a self-expandable interior stent defining a lumen supporting a plurality of valve leaflets, the interior stent covered at least in part by a sealing skirt, the interior stent having a plurality of native leaflet capturing elements extending from a ventricular end; anda self-expandable exterior wire mesh surrounding the interior stent, the exterior wire mesh extending along substantially an entire length of the interior stent, the exterior wire mesh having a lower radial strength than the interior stent for conforming to a native mitral valve, the exterior wire mesh attached to an atrial end of the interior stent;expelling the prosthetic mitral valve from the distal capsule;allowing the prosthetic mitral valve to self-expand within the native mitral valve;wherein, in an expanded state, the exterior wire mesh has an enlarged diameter positioned above a mitral annulus and a reduced diameter contacting the mitral annulus and wherein the capturing elements of the interior stent extend in a ventricular direction beyond the exterior wire mesh and then turn in an atrial direction such that native mitral leaflets are trapped between the capturing elements and an outer surface of the wire mesh.
  • 2. The method according to claim 1, wherein the wire mesh reaches the ventricular end of the interior stent.
  • 3. The method according to claim 1, wherein the wire mesh extends beyond the ventricular end of the interior stent.
  • 4. The method according to claim 1, wherein the distal capsule is tapered along its proximal and distal ends for facilitating advancement and retraction.
  • 5. The method according to claim 1, wherein the native leaflet capturing elements have different shapes.
  • 6. The method according to claim 1, wherein the wire mesh comprises a fabric sealing material.
  • 7. The method according to claim 1, wherein the delivery catheter is advanced over a guide wire to the native mitral valve.
  • 8. The method according to claim 1, wherein the wire mesh includes barbs or spikes along the outer surface.
  • 9. The method according to claim 1, wherein a handle is provided on the proximal end portion of the delivery catheter and wherein knobs on the handle are actuated for releasing the prosthetic mitral valve from the distal capsule.
  • 10. A method of implanting a prosthetic valve in a native valve, comprising: advancing a flexible elongate delivery catheter into a human heart and toward a native valve, the delivery catheter having a distal capsule containing a prosthetic valve in a compressed state, the prosthetic valve including: a self-expandable interior stent defining a lumen supporting a plurality of leaflets, the interior stent covered at least in part by a fabric sealing skirt, the interior stent having a plurality of capturing elements extending from a ventricular end; anda self-expandable exterior wire mesh surrounding the interior stent, the exterior wire mesh extending along substantially an entire length of the interior stent, the exterior wire mesh having a lower radial strength than the interior stent for conforming to a shape of a native valve, wherein the exterior wire mesh is attached to an atrial end portion of the interior stent;expelling the prosthetic valve from the distal capsule;allowing the prosthetic valve to self-expand within the native valve;wherein, in an expanded state, the exterior wire mesh has an enlarged diameter positioned on an atrial side of a native annulus and a reduced diameter contacting the native annulus and wherein the capturing elements of the interior stent extend in a ventricular direction beyond the exterior wire mesh and then turn in an atrial direction such that leaflets of the native valve are positioned between the capturing elements and an outer surface of the wire mesh.
  • 11. The method according to claim 10, wherein the wire mesh reaches the ventricular end of the interior stent.
  • 12. The method according to claim 10, wherein the wire mesh extends beyond the ventricular end of the interior stent.
  • 13. The method according to claim 10, wherein the distal capsule is tapered along its proximal and distal ends for facilitating advancement and retraction.
  • 14. The method according to claim 10, wherein the native leaflet capturing elements have different shapes.
  • 15. The method according to claim 10, wherein the interior stent and exterior wire mesh are both made of nitinol.
  • 16. The method according to claim 10, wherein the delivery catheter is advanced over a guide wire to the native valve.
  • 17. The method according to claim 10, wherein the wire mesh includes barbs or spikes along the outer surface for enhancing securement to the native valve.
  • 18. The method according to claim 10, wherein a handle is provided on the proximal end portion of the delivery catheter and wherein knobs on the handle are actuated for releasing the prosthetic valve from the distal capsule.
Priority Claims (1)
Number Date Country Kind
20140100595 Nov 2014 GR national
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 16/740,916, filed Jan. 13, 2020, now U.S. Pat. No. 11,559,395, which is a continuation of U.S. application Ser. No. 15/526,810, filed May 15, 2017, now U.S. Pat. No. 10,531,951, which is a U.S. National Stage entry of International Application No. PCT/EP2015/077856, filed on Nov. 26, 2015, which claims priority to Greek Patent Application No. 20140100595, filed on Nov. 26, 2014, each of which is hereby incorporated by reference herein in its entirety.

US Referenced Citations (676)
Number Name Date Kind
3409013 Berry Nov 1968 A
3472230 Fogarty Oct 1969 A
3548417 Kisher Dec 1970 A
3587115 Shiley Jun 1971 A
3657744 Ersek Apr 1972 A
3671979 Moulopoulos Jun 1972 A
3714671 Edwards et al. Feb 1973 A
3739402 Cooley et al. Jun 1973 A
3755823 Hancock Sep 1973 A
4035849 Angell et al. Jul 1977 A
4056854 Boretos et al. Nov 1977 A
4079468 Liotta et al. Mar 1978 A
4106129 Carpentier et al. Aug 1978 A
4204283 Bellhouse et al. May 1980 A
4222126 Boretos et al. Sep 1980 A
4265694 Boretos et al. May 1981 A
4297749 Davis et al. Nov 1981 A
4339831 Johnson Jul 1982 A
4340977 Brownlee et al. Jul 1982 A
4343048 Ross et al. Aug 1982 A
4345340 Rosen Aug 1982 A
4373216 Klawitter Feb 1983 A
4406022 Roy Sep 1983 A
4470157 Love Sep 1984 A
4477930 Totten et al. Oct 1984 A
4490859 Black et al. Jan 1985 A
4535483 Klawitter et al. Aug 1985 A
4553545 Maass et al. Nov 1985 A
4574803 Storz Mar 1986 A
4592340 Boyles Jun 1986 A
4605407 Black et al. Aug 1986 A
4612011 Kautzky Sep 1986 A
4643732 Pietsch et al. Feb 1987 A
4655771 Wallsten Apr 1987 A
4692164 Dzemeshkevich et al. Sep 1987 A
4733665 Palmaz Mar 1988 A
4759758 Gabbay Jul 1988 A
4762128 Rosenbluth Aug 1988 A
4777951 Cribier et al. Oct 1988 A
4787899 Lazarus Nov 1988 A
4787901 Baykut Nov 1988 A
4796629 Grayzel Jan 1989 A
4829990 Thuroff et al. May 1989 A
4851001 Taheri Jul 1989 A
4856516 Hillstead Aug 1989 A
4865600 Carpentier et al. Sep 1989 A
4878495 Grayzel Nov 1989 A
4878906 Lindemann et al. Nov 1989 A
4883458 Shiber Nov 1989 A
4922905 Strecker May 1990 A
4966604 Reiss Oct 1990 A
4979939 Shiber Dec 1990 A
4986830 Owens et al. Jan 1991 A
4994077 Dobben Feb 1991 A
5007896 Shiber Apr 1991 A
5026366 Leckrone Jun 1991 A
5032128 Alonso Jul 1991 A
5037434 Lane Aug 1991 A
5047041 Samuels Sep 1991 A
5059177 Towne et al. Oct 1991 A
5080668 Bolz et al. Jan 1992 A
5085635 Cragg Feb 1992 A
5089015 Ross Feb 1992 A
5108370 Walinsky Apr 1992 A
5152771 Sabbaghian et al. Oct 1992 A
5163953 Vince Nov 1992 A
5167628 Boyles Dec 1992 A
5192297 Hull Mar 1993 A
5232446 Arney Aug 1993 A
5266073 Wall Nov 1993 A
5282847 Trescony et al. Feb 1994 A
5295958 Shturman Mar 1994 A
5326371 Love et al. Jul 1994 A
5332402 Teitelbaum Jul 1994 A
5360444 Kusuhara Nov 1994 A
5370685 Stevens Dec 1994 A
5397351 Pavcnik et al. Mar 1995 A
5411055 Kane May 1995 A
5411522 Trott May 1995 A
5411552 Andersen et al. May 1995 A
5415667 Frater May 1995 A
5443446 Shturman Aug 1995 A
5480424 Cox Jan 1996 A
5500014 Quijano et al. Mar 1996 A
5545209 Roberts et al. Aug 1996 A
5545214 Stevens Aug 1996 A
5549665 Vesely et al. Aug 1996 A
5554185 Block et al. Sep 1996 A
5571175 Vanney et al. Nov 1996 A
5591185 Kilmer et al. Jan 1997 A
5599305 Hermann et al. Feb 1997 A
5607464 Trescony et al. Mar 1997 A
5609626 Quijano et al. Mar 1997 A
5639274 Fischell et al. Jun 1997 A
5665115 Cragg Sep 1997 A
5697382 Love et al. Dec 1997 A
5716417 Girard et al. Feb 1998 A
5728068 Leone et al. Mar 1998 A
5749890 Shaknovich May 1998 A
5756476 Epstein et al. May 1998 A
5769812 Stevens et al. Jun 1998 A
5800508 Goicoechea et al. Sep 1998 A
5840081 Andersen et al. Nov 1998 A
5855597 Jayaraman Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5855602 Angell Jan 1999 A
5906619 Olson et al. May 1999 A
5925063 Khosravi Jul 1999 A
5957949 Leonhardt et al. Sep 1999 A
5968068 Dehdashtian et al. Oct 1999 A
6027525 Suh et al. Feb 2000 A
6042607 Williamson, IV et al. Mar 2000 A
6086612 Jansen Jul 2000 A
6113631 Jansen Sep 2000 A
6132473 Williams et al. Oct 2000 A
6168614 Andersen et al. Jan 2001 B1
6171335 Wheatley et al. Jan 2001 B1
6174327 Mertens et al. Jan 2001 B1
6210408 Chandrasekaran et al. Apr 2001 B1
6217585 Houser et al. Apr 2001 B1
6221091 Khosravi Apr 2001 B1
6231602 Carpentier et al. May 2001 B1
6245040 Inderbitzen et al. Jun 2001 B1
6245100 Davila Jun 2001 B1
6245102 Jayaraman Jun 2001 B1
6251093 Valley et al. Jun 2001 B1
6287339 Vazquez et al. Sep 2001 B1
6299637 Shaolian et al. Oct 2001 B1
6302906 Goecoechea et al. Oct 2001 B1
6306141 Jervis Oct 2001 B1
6312465 Griffin et al. Nov 2001 B1
6350277 Kocur Feb 2002 B1
6358277 Duran Mar 2002 B1
6379372 Dehdashtian et al. Apr 2002 B1
6425916 Garrison et al. Jul 2002 B1
6440164 Matteo et al. Aug 2002 B1
6454799 Schreck Sep 2002 B1
6458153 Bailey et al. Oct 2002 B1
6461382 Cao Oct 2002 B1
6468660 Ogle et al. Oct 2002 B2
6482228 Norred Nov 2002 B1
6488704 Connelly et al. Dec 2002 B1
6527800 McGuckin, Jr. et al. Mar 2003 B1
6527979 Constantz Mar 2003 B2
6540782 Snyders Apr 2003 B1
6569196 Vesely May 2003 B1
6575959 Sarge et al. Jun 2003 B1
6582462 Andersen et al. Jun 2003 B1
6605112 Moll et al. Aug 2003 B1
6610088 Gabbay Aug 2003 B1
6629534 St. Goar et al. Oct 2003 B1
6676698 McGuckin, Jr. et al. Jan 2004 B2
6695878 McGuckin, Jr. et al. Feb 2004 B2
6712836 Berg et al. Mar 2004 B1
6716207 Farnholtz Apr 2004 B2
6729356 Baker et al. May 2004 B1
6730118 Spenser et al. May 2004 B2
6733525 Yang et al. May 2004 B2
6746422 Noriega et al. Jun 2004 B1
6749560 Konstorum et al. Jun 2004 B1
6767362 Schreck Jul 2004 B2
6780200 Jansen Aug 2004 B2
6790229 Berreklouw Sep 2004 B1
6790230 Beyersdorf et al. Sep 2004 B2
6830584 Seguin Dec 2004 B1
6875231 Anduiza et al. Apr 2005 B2
6893460 Spenser et al. May 2005 B2
6908481 Cribier Jun 2005 B2
6974476 McGuckin, Jr. et al. Dec 2005 B2
7018406 Seguin et al. Mar 2006 B2
7186265 Sharkawy et al. Mar 2007 B2
7192440 Andreas et al. Mar 2007 B2
7198646 Figulla et al. Apr 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7276078 Spenser et al. Oct 2007 B2
7276084 Yang et al. Oct 2007 B2
7318278 Zhang et al. Jan 2008 B2
7374571 Pease et al. May 2008 B2
7381210 Zarbatany et al. Jun 2008 B2
7381219 Salahieh et al. Jun 2008 B2
7393360 Spenser et al. Jul 2008 B2
7429269 Schwammenthal et al. Sep 2008 B2
7442204 Schwammenthal et al. Oct 2008 B2
7445631 Salahieh et al. Nov 2008 B2
7462191 Spenser et al. Dec 2008 B2
7510575 Spenser et al. Mar 2009 B2
7524330 Berreklouw Apr 2009 B2
7530253 Spenser et al. May 2009 B2
7553324 Andreas et al. Jun 2009 B2
7579381 Dove Aug 2009 B2
7585321 Cribier Sep 2009 B2
7618446 Andersen et al. Nov 2009 B2
7621948 Herrmann et al. Nov 2009 B2
7704222 Wilk et al. Apr 2010 B2
7736327 Wilk et al. Jun 2010 B2
7748389 Salahieh et al. Jul 2010 B2
7753949 Lamphere et al. Jul 2010 B2
7806919 Bloom et al. Oct 2010 B2
7824443 Salahieh et al. Nov 2010 B2
7837727 Goetz et al. Nov 2010 B2
7892281 Seguin et al. Feb 2011 B2
7914569 Nguyen et al. Mar 2011 B2
7914575 Guyenot et al. Mar 2011 B2
7959672 Salahieh et al. Jun 2011 B2
7972378 Tabor et al. Jul 2011 B2
7981151 Rowe Jul 2011 B2
7993392 Righini et al. Aug 2011 B2
7993394 Hariton et al. Aug 2011 B2
8007992 Tian et al. Aug 2011 B2
8016877 Seguin et al. Sep 2011 B2
8029556 Rowe Oct 2011 B2
8052750 Tuval et al. Nov 2011 B2
8070800 Lock et al. Dec 2011 B2
8070802 Lamphere et al. Dec 2011 B2
8075615 Eberhardt et al. Dec 2011 B2
8080054 Rowe Dec 2011 B2
8092520 Quadri Jan 2012 B2
8092521 Figulla et al. Jan 2012 B2
8109996 Stacchino et al. Feb 2012 B2
8118866 Herrmann et al. Feb 2012 B2
8136218 Millwee et al. Mar 2012 B2
8137398 Tuval et al. Mar 2012 B2
8157852 Bloom et al. Apr 2012 B2
8167932 Bourang May 2012 B2
8167934 Styrc et al. May 2012 B2
8182530 Huber May 2012 B2
8206437 Bonhoeffer et al. Jun 2012 B2
8216174 Wilk et al. Jul 2012 B2
8216301 Bonhoeffer et al. Jul 2012 B2
8219229 Cao et al. Jul 2012 B2
8220121 Hendriksen et al. Jul 2012 B2
8236045 Benichou et al. Aug 2012 B2
8246675 Zegdi Aug 2012 B2
8246678 Salahieh et al. Aug 2012 B2
8252051 Chau et al. Aug 2012 B2
8252052 Salahieh et al. Aug 2012 B2
8287584 Salahieh et al. Oct 2012 B2
8313525 Tuval et al. Nov 2012 B2
8317858 Straubinger et al. Nov 2012 B2
8323335 Rowe et al. Dec 2012 B2
8337541 Quadri et al. Dec 2012 B2
8353953 Giannetti et al. Jan 2013 B2
8398704 Straubinger et al. Mar 2013 B2
8403983 Quadri et al. Mar 2013 B2
8414644 Quadri et al. Apr 2013 B2
8414645 Dwork et al. Apr 2013 B2
8416643 Magee Apr 2013 B2
8444689 Zhang May 2013 B2
8449599 Chau et al. May 2013 B2
8454685 Hariton et al. Jun 2013 B2
8460368 Taylor et al. Jun 2013 B2
8460370 Zakay Jun 2013 B2
8470023 Eidenschink et al. Jun 2013 B2
8470028 Thornton et al. Jun 2013 B2
8475521 Suri et al. Jul 2013 B2
8475523 Duffy Jul 2013 B2
8479380 Malewicz et al. Jul 2013 B2
8491650 Wiemeyer et al. Jul 2013 B2
8500733 Watson Aug 2013 B2
8500798 Rowe et al. Aug 2013 B2
8511244 Holecek et al. Aug 2013 B2
8512401 Murray, III et al. Aug 2013 B2
8518096 Nelson Aug 2013 B2
8518106 Duffy et al. Aug 2013 B2
8562663 Mearns et al. Oct 2013 B2
8579963 Tabor Nov 2013 B2
8579964 Lane et al. Nov 2013 B2
8591570 Revuelta et al. Nov 2013 B2
8617236 Paul et al. Dec 2013 B2
8640521 Righini et al. Feb 2014 B2
8647381 Essinger et al. Feb 2014 B2
8652145 Maimon et al. Feb 2014 B2
8652201 Oberti et al. Feb 2014 B2
8652202 Alon et al. Feb 2014 B2
8652203 Quadri et al. Feb 2014 B2
8668733 Haug et al. Mar 2014 B2
8679174 Ottma et al. Mar 2014 B2
8679404 Liburd et al. Mar 2014 B2
8685086 Navia et al. Apr 2014 B2
8721708 Seguin et al. May 2014 B2
8721714 Kelley May 2014 B2
8728154 Alkhatib May 2014 B2
8728155 Montorfano et al. May 2014 B2
8740974 Lambrecht et al. Jun 2014 B2
8740976 Tran et al. Jun 2014 B2
8747458 Tuval et al. Jun 2014 B2
8747459 Nguyen et al. Jun 2014 B2
8758432 Solem Jun 2014 B2
8764818 Gregg Jul 2014 B2
8771344 Tran et al. Jul 2014 B2
8778020 Gregg et al. Jul 2014 B2
8784337 Voeller et al. Jul 2014 B2
8784478 Tuval et al. Jul 2014 B2
8784481 Alkhatib et al. Jul 2014 B2
8790387 Nguyen et al. Jul 2014 B2
8795357 Yohanan et al. Aug 2014 B2
8808356 Braido et al. Aug 2014 B2
8828078 Salahieh et al. Sep 2014 B2
8828079 Thielen et al. Sep 2014 B2
8834564 Tuval et al. Sep 2014 B2
8858620 Salahieh et al. Oct 2014 B2
8870948 Erzberger et al. Oct 2014 B1
8870950 Hacohen Oct 2014 B2
8876893 Dwork et al. Nov 2014 B2
8911455 Quadri et al. Dec 2014 B2
8926693 Duffy et al. Jan 2015 B2
8926694 Costello Jan 2015 B2
8939960 Rosenman et al. Jan 2015 B2
8945209 Bonyuet et al. Feb 2015 B2
8961593 Bonhoeffer et al. Feb 2015 B2
8961595 Alkhatib Feb 2015 B2
8974524 Yeung et al. Mar 2015 B2
8979922 Jayasinghe et al. Mar 2015 B2
8986375 Garde et al. Mar 2015 B2
8998980 Shipley et al. Apr 2015 B2
9005273 Salahieh et al. Apr 2015 B2
9011521 Haug et al. Apr 2015 B2
9011523 Seguin Apr 2015 B2
9011524 Eberhardt Apr 2015 B2
9028545 Taylor May 2015 B2
9034032 McLean et al. May 2015 B2
9055937 Rowe et al. Jun 2015 B2
9066801 Kovalsky et al. Jun 2015 B2
9078749 Lutter et al. Jul 2015 B2
9078751 Naor Jul 2015 B2
9125738 Figulla et al. Sep 2015 B2
9173737 Hill et al. Nov 2015 B2
9180004 Alkhatib Nov 2015 B2
9186249 Rolando et al. Nov 2015 B2
9277990 Klima et al. Mar 2016 B2
9277993 Gamarra et al. Mar 2016 B2
9289291 Gorman, III et al. Mar 2016 B2
9295551 Straubinger et al. Mar 2016 B2
9445897 Bishop et al. Sep 2016 B2
9456877 Weitzner et al. Oct 2016 B2
9681968 Goetz et al. Jun 2017 B2
9687345 Rabito et al. Jun 2017 B2
9700329 Metzger et al. Jul 2017 B2
9700411 Klima et al. Jul 2017 B2
9724083 Quadri et al. Aug 2017 B2
9730790 Quadri et al. Aug 2017 B2
9730791 Ratz et al. Aug 2017 B2
9795479 Lim et al. Oct 2017 B2
9833313 Board et al. Dec 2017 B2
9861473 Lafontaine Jan 2018 B2
9861476 Salahieh et al. Jan 2018 B2
9861477 Backus et al. Jan 2018 B2
9867698 Kovalsky et al. Jan 2018 B2
9877830 Lim et al. Jan 2018 B2
9889029 Li et al. Feb 2018 B2
9895225 Rolando et al. Feb 2018 B2
9925045 Creaven et al. Mar 2018 B2
10004599 Rabito et al. Jun 2018 B2
10117744 Ratz et al. Nov 2018 B2
10179044 Ratz et al. Jan 2019 B2
10219897 Essinger et al. Mar 2019 B2
10350065 Quadri Jul 2019 B2
10350066 Cooper et al. Jul 2019 B2
10376363 Quadri et al. Aug 2019 B2
10531951 Spargias Jan 2020 B2
10555809 Hastings et al. Feb 2020 B2
10575951 Johnson et al. Mar 2020 B2
10583000 Ratz et al. Mar 2020 B2
10639146 Quadri et al. May 2020 B2
10695177 Hariton et al. Jun 2020 B2
10758344 Hariton et al. Sep 2020 B2
11406499 Zhang et al. Aug 2022 B2
11452598 Essinger et al. Sep 2022 B2
11559395 Spargias Jan 2023 B2
11672658 Hariton et al. Jun 2023 B2
11701225 Hammer et al. Jul 2023 B2
11903829 Ma et al. Feb 2024 B1
20010021872 Bailey et al. Sep 2001 A1
20020032481 Gabbay Mar 2002 A1
20020045929 Diaz Apr 2002 A1
20020052644 Shaolian et al. May 2002 A1
20020173842 Buchanan Nov 2002 A1
20030050694 Yang et al. Mar 2003 A1
20030100939 Yodfat et al. May 2003 A1
20030105517 White et al. Jun 2003 A1
20030120333 Ouriel et al. Jun 2003 A1
20030130729 Paniagua et al. Jul 2003 A1
20030158597 Quiachon et al. Aug 2003 A1
20030176914 Rabkin et al. Sep 2003 A1
20030199971 Tower et al. Oct 2003 A1
20030212454 Scott et al. Nov 2003 A1
20030220683 Minasian et al. Nov 2003 A1
20040039436 Spenser et al. Feb 2004 A1
20040092858 Wilson et al. May 2004 A1
20040117009 Cali et al. Jun 2004 A1
20040133263 Dusbabek et al. Jul 2004 A1
20040133273 Cox Jul 2004 A1
20040186563 Lobbi Sep 2004 A1
20040186565 Schreck Sep 2004 A1
20040210307 Khairkhahan Oct 2004 A1
20040215325 Penn et al. Oct 2004 A1
20040225353 McGuckin et al. Nov 2004 A1
20040236411 Sarac et al. Nov 2004 A1
20040260389 Case et al. Dec 2004 A1
20050033398 Seguin Feb 2005 A1
20050075727 Wheatley Apr 2005 A1
20050090887 Pryor Apr 2005 A1
20050096738 Cali et al. May 2005 A1
20050107872 Mensah et al. May 2005 A1
20050137682 Justino Jun 2005 A1
20050137686 Salahieh et al. Jun 2005 A1
20050137687 Salahieh et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137691 Salahieh et al. Jun 2005 A1
20050137698 Salahieh et al. Jun 2005 A1
20050159811 Lane Jul 2005 A1
20050182486 Gabbay Aug 2005 A1
20050203614 Forster et al. Sep 2005 A1
20050203617 Forster et al. Sep 2005 A1
20050216079 MaCoviak Sep 2005 A1
20050234546 Nugent et al. Oct 2005 A1
20050288766 Plain et al. Dec 2005 A1
20060020327 Lashinski et al. Jan 2006 A1
20060025857 Bergheim et al. Feb 2006 A1
20060058872 Salahieh et al. Mar 2006 A1
20060095115 Bladillah et al. May 2006 A1
20060142837 Haverkost et al. Jun 2006 A1
20060149350 Patel et al. Jul 2006 A1
20060161249 Realyvasquez et al. Jul 2006 A1
20060173537 Yang et al. Aug 2006 A1
20060195134 Crittenden Aug 2006 A1
20060195183 Navia et al. Aug 2006 A1
20060212110 Osborne et al. Sep 2006 A1
20060229719 Marquez et al. Oct 2006 A1
20060241745 Solem Oct 2006 A1
20060259135 Navia et al. Nov 2006 A1
20060259137 Artof et al. Nov 2006 A1
20060276874 Wilson et al. Dec 2006 A1
20060293745 Carpentier et al. Dec 2006 A1
20070005131 Taylor Jan 2007 A1
20070010877 Salahieh et al. Jan 2007 A1
20070027534 Bergheim et al. Feb 2007 A1
20070043435 Seguin et al. Feb 2007 A1
20070050021 Johnson Mar 2007 A1
20070066863 Rafiee et al. Mar 2007 A1
20070088431 Bourang et al. Apr 2007 A1
20070100432 Case et al. May 2007 A1
20070100439 Cangialosi et al. May 2007 A1
20070112422 Dehdashtian May 2007 A1
20070129794 Realyvasquez Jun 2007 A1
20070142906 Figulla et al. Jun 2007 A1
20070156224 Cioanta et al. Jul 2007 A1
20070203503 Salahieh et al. Aug 2007 A1
20070203575 Forster et al. Aug 2007 A1
20070213813 Von Segesser et al. Sep 2007 A1
20070255394 Ryan Nov 2007 A1
20070270943 Solem et al. Nov 2007 A1
20080021546 Patz et al. Jan 2008 A1
20080065011 Marchand et al. Mar 2008 A1
20080071361 Tuval et al. Mar 2008 A1
20080071362 Tuval et al. Mar 2008 A1
20080071363 Tuval et al. Mar 2008 A1
20080071366 Tuval et al. Mar 2008 A1
20080071368 Tuval et al. Mar 2008 A1
20080071369 Tuval et al. Mar 2008 A1
20080082164 Friedman Apr 2008 A1
20080082165 Wilson et al. Apr 2008 A1
20080082166 Styrc et al. Apr 2008 A1
20080097581 Shanley Apr 2008 A1
20080114442 Mitchell et al. May 2008 A1
20080125853 Bailey et al. May 2008 A1
20080147179 Cai et al. Jun 2008 A1
20080147183 Styrc Jun 2008 A1
20080154355 Benichou et al. Jun 2008 A1
20080177381 Navia et al. Jul 2008 A1
20080183273 Mesana et al. Jul 2008 A1
20080208328 Antocci et al. Aug 2008 A1
20080208332 Lamphere et al. Aug 2008 A1
20080221672 Lamphere et al. Sep 2008 A1
20080228254 Ryan Sep 2008 A1
20080255660 Guyenot et al. Oct 2008 A1
20080255661 Straubinger et al. Oct 2008 A1
20080281411 Berreklouw Nov 2008 A1
20090005863 Goetz et al. Jan 2009 A1
20090054968 Bonhoeffer et al. Feb 2009 A1
20090054974 McGuckin, Jr. et al. Feb 2009 A1
20090076598 Salahieh et al. Mar 2009 A1
20090112309 Jaramillo et al. Apr 2009 A1
20090138079 Tuval et al. May 2009 A1
20090157175 Benichou Jun 2009 A1
20090164005 Dove et al. Jun 2009 A1
20090171432 Von Segesser et al. Jul 2009 A1
20090171447 Von Segesser et al. Jul 2009 A1
20090171456 Kveen et al. Jul 2009 A1
20090182413 Burkart et al. Jul 2009 A1
20090188964 Orlov Jul 2009 A1
20090216310 Straubinger et al. Aug 2009 A1
20090216313 Straubinger et al. Aug 2009 A1
20090216322 Le et al. Aug 2009 A1
20090222076 Figulla et al. Sep 2009 A1
20090234443 Ottma et al. Sep 2009 A1
20090240320 Tuval et al. Sep 2009 A1
20090270972 Lane Oct 2009 A1
20090276027 Glynn Nov 2009 A1
20090276040 Rowe et al. Nov 2009 A1
20090281618 Hill et al. Nov 2009 A1
20090281619 Le et al. Nov 2009 A1
20090287296 Manasse Nov 2009 A1
20090287299 Tabor et al. Nov 2009 A1
20090292350 Eberhardt et al. Nov 2009 A1
20090306768 Quadri Dec 2009 A1
20090319037 Rowe et al. Dec 2009 A1
20100016958 St. Goar et al. Jan 2010 A1
20100049313 Alon et al. Feb 2010 A1
20100069852 Kelley Mar 2010 A1
20100114305 Kang et al. May 2010 A1
20100131054 Tuval et al. May 2010 A1
20100137979 Tuval et al. Jun 2010 A1
20100174362 Straubinger et al. Jul 2010 A1
20100191326 Alkhatib Jul 2010 A1
20100204781 Alkhatib Aug 2010 A1
20100217382 Chau et al. Aug 2010 A1
20100249894 Oba et al. Sep 2010 A1
20100249911 Alkhatib Sep 2010 A1
20100256723 Murray Oct 2010 A1
20100262231 Tuval et al. Oct 2010 A1
20100305685 Millwee et al. Dec 2010 A1
20110015616 Straubinger et al. Jan 2011 A1
20110015729 Jimenez et al. Jan 2011 A1
20110137397 Chau et al. Jun 2011 A1
20110208290 Straubinger et al. Aug 2011 A1
20110208297 Tuval et al. Aug 2011 A1
20110208298 Tuval et al. Aug 2011 A1
20110224785 Hacohen Sep 2011 A1
20110238159 Guyenot et al. Sep 2011 A1
20110264196 Savage et al. Oct 2011 A1
20110264198 Murray, III et al. Oct 2011 A1
20110288634 Tuval et al. Nov 2011 A1
20110313515 Quadri et al. Dec 2011 A1
20110319989 Lane et al. Dec 2011 A1
20120022639 Hacohen et al. Jan 2012 A1
20120035722 Tuval Feb 2012 A1
20120041550 Salahieh et al. Feb 2012 A1
20120046741 Tuval et al. Feb 2012 A1
20120046742 Tuval et al. Feb 2012 A1
20120078360 Rafiee Mar 2012 A1
20120101570 Tuval et al. Apr 2012 A1
20120101571 Thambar et al. Apr 2012 A1
20120101572 Kovalsky et al. Apr 2012 A1
20120123529 Levi et al. May 2012 A1
20120185039 Tuval et al. Jul 2012 A1
20120197386 Von Segesser et al. Aug 2012 A1
20120209374 Bonhoeffer et al. Aug 2012 A1
20120215303 Quadri et al. Aug 2012 A1
20120271398 Essinger et al. Oct 2012 A1
20120283823 Bonhoeffer et al. Nov 2012 A1
20120290062 McNamara et al. Nov 2012 A1
20120296418 Bonyuet et al. Nov 2012 A1
20120310328 Olson et al. Dec 2012 A1
20120310336 Figulla et al. Dec 2012 A1
20130006294 Kashkarov et al. Jan 2013 A1
20130035759 Gross et al. Feb 2013 A1
20130073035 Tuval et al. Mar 2013 A1
20130079869 Straubinger et al. Mar 2013 A1
20130190861 Chau et al. Jul 2013 A1
20130190862 Pintor et al. Jul 2013 A1
20130197622 Mitra et al. Aug 2013 A1
20130211508 Lane et al. Aug 2013 A1
20130253635 Straubinger et al. Sep 2013 A1
20130253642 Brecker Sep 2013 A1
20130310928 Morriss Nov 2013 A1
20130331929 Mitra et al. Dec 2013 A1
20130338766 Hastings et al. Dec 2013 A1
20130345786 Behan Dec 2013 A1
20140018912 Delaloye et al. Jan 2014 A1
20140025163 Padala et al. Jan 2014 A1
20140039611 Lane et al. Feb 2014 A1
20140052237 Lane et al. Feb 2014 A1
20140100651 Kheradvar et al. Apr 2014 A1
20140163668 Rafiee Jun 2014 A1
20140172077 Bruchman et al. Jun 2014 A1
20140172083 Bruchman et al. Jun 2014 A1
20140194981 Menk et al. Jul 2014 A1
20140207231 Hacohen et al. Jul 2014 A1
20140214157 Bortlein et al. Jul 2014 A1
20140222139 Nguyen et al. Aug 2014 A1
20140222142 Kovalsky et al. Aug 2014 A1
20140222144 Eberhardt et al. Aug 2014 A1
20140243966 Garde et al. Aug 2014 A1
20140257467 Lane et al. Sep 2014 A1
20140277390 Ratz et al. Sep 2014 A1
20140277412 Bortlein et al. Sep 2014 A1
20140277422 Ratz et al. Sep 2014 A1
20140277427 Ratz et al. Sep 2014 A1
20140296973 Bergheim et al. Oct 2014 A1
20140296975 Tegels et al. Oct 2014 A1
20140303719 Cox et al. Oct 2014 A1
20140309728 Dehdashtian et al. Oct 2014 A1
20140324160 Benichou et al. Oct 2014 A1
20140324164 Gross et al. Oct 2014 A1
20140330368 Gloss et al. Nov 2014 A1
20140330371 Gloss et al. Nov 2014 A1
20140330372 Weston et al. Nov 2014 A1
20140336754 Gurskis et al. Nov 2014 A1
20140343669 Lane et al. Nov 2014 A1
20140343670 Bakis et al. Nov 2014 A1
20140350666 Righini Nov 2014 A1
20140350668 Delaloye et al. Nov 2014 A1
20140358223 Rafiee et al. Dec 2014 A1
20140364939 Deshmukh et al. Dec 2014 A1
20140364943 Conklin Dec 2014 A1
20140371842 Marquez et al. Dec 2014 A1
20140371844 Dale et al. Dec 2014 A1
20140371847 Madrid et al. Dec 2014 A1
20140371848 Murray, III et al. Dec 2014 A1
20150005863 Para Jan 2015 A1
20150018944 O'Connell et al. Jan 2015 A1
20150039083 Rafiee Feb 2015 A1
20150142103 Vidlund May 2015 A1
20150148731 McNamara et al. May 2015 A1
20150173897 Raanani et al. Jun 2015 A1
20150196390 Ma et al. Jul 2015 A1
20150209141 Braido et al. Jul 2015 A1
20150272737 Dale et al. Oct 2015 A1
20150297346 Duffy et al. Oct 2015 A1
20150305860 Wang Oct 2015 A1
20150335429 Morriss et al. Nov 2015 A1
20150351903 Morriss et al. Dec 2015 A1
20150359629 Ganesan et al. Dec 2015 A1
20160000591 Lei et al. Jan 2016 A1
20160030169 Shahriari Feb 2016 A1
20160030170 Alkhatib et al. Feb 2016 A1
20160030171 Quijano et al. Feb 2016 A1
20160038281 Delaloye et al. Feb 2016 A1
20160074160 Christianson et al. Mar 2016 A1
20160106537 Christianson et al. Apr 2016 A1
20160113765 Ganesan et al. Apr 2016 A1
20160113768 Ganesan et al. Apr 2016 A1
20160143732 Glimsdale May 2016 A1
20160158010 Lim et al. Jun 2016 A1
20160166383 Lim et al. Jun 2016 A1
20160184097 Lim et al. Jun 2016 A1
20160199206 Lim et al. Jul 2016 A1
20160213473 Hacohen et al. Jul 2016 A1
20160235529 Ma et al. Aug 2016 A1
20160279386 Dale et al. Sep 2016 A1
20160310267 Zeng et al. Oct 2016 A1
20170128209 Morriss et al. May 2017 A1
20170216023 Lane et al. Aug 2017 A1
20170216575 Asleson et al. Aug 2017 A1
20170258614 Griffin Sep 2017 A1
20170325954 Perszyk Nov 2017 A1
20170348096 Anderson Dec 2017 A1
20170367821 Landon et al. Dec 2017 A1
20170367823 Hariton et al. Dec 2017 A1
20180021129 Peterson et al. Jan 2018 A1
20180055629 Oba et al. Mar 2018 A1
20180055636 Valencia et al. Mar 2018 A1
20180085218 Eidenschink Mar 2018 A1
20180110534 Gavala et al. Apr 2018 A1
20180116790 Ratz et al. May 2018 A1
20190008639 Landon et al. Jan 2019 A1
20190008640 Cooper et al. Jan 2019 A1
20190262129 Cooper et al. Aug 2019 A1
20200000579 Manash et al. Jan 2020 A1
20200108225 Jamal et al. Apr 2020 A1
20200345494 Srinimukesh et al. Nov 2020 A1
20200352718 Rowe et al. Nov 2020 A1
20210145576 Becerra et al. May 2021 A1
20210378817 Nia et al. Dec 2021 A1
20210386544 Cooper et al. Dec 2021 A1
20220142777 Scheinblum et al. May 2022 A1
20220287836 Landon et al. Sep 2022 A1
20220346993 Srinimukesh et al. Nov 2022 A1
20230000624 Okabe et al. Jan 2023 A1
20230200980 Peterson et al. Jun 2023 A1
20230218391 Dass et al. Jul 2023 A1
20230380963 Kaufman et al. Nov 2023 A1
20230390052 Okafor et al. Dec 2023 A1
20230404753 Luong et al. Dec 2023 A1
20240008978 Nawalakhe et al. Jan 2024 A1
Foreign Referenced Citations (141)
Number Date Country
2304325 Oct 2000 CA
2246526 Mar 1973 DE
19532846 Mar 1997 DE
19546692 Jun 1997 DE
19857887 Jul 2000 DE
19907646 Aug 2000 DE
10010074 Oct 2001 DE
10049812 Apr 2002 DE
10049813 Apr 2002 DE
10049814 Apr 2002 DE
10049815 Apr 2002 DE
102006052564 Dec 2007 DE
0103546 Mar 1984 EP
0144167 Jun 1985 EP
0592410 Apr 1994 EP
0597967 May 1994 EP
0850607 Jul 1998 EP
1057460 Dec 2000 EP
1088529 Apr 2001 EP
1171059 Jan 2002 EP
1239901 Sep 2002 EP
1255510 Nov 2002 EP
1259194 Nov 2002 EP
1369098 Dec 2003 EP
1469797 Oct 2004 EP
1472996 Nov 2004 EP
1570809 Sep 2005 EP
1653888 May 2006 EP
1849440 Oct 2007 EP
1935377 Jun 2008 EP
2124826 Dec 2009 EP
2168536 Mar 2010 EP
2413842 Feb 2012 EP
2446915 May 2012 EP
2745805 Jun 2014 EP
2749254 Jul 2014 EP
2750630 Jul 2014 EP
2777616 Sep 2014 EP
2777617 Sep 2014 EP
2918249 Sep 2015 EP
2948103 Dec 2015 EP
2967858 Jan 2016 EP
3037064 Jun 2016 EP
3046511 Jul 2016 EP
3057541 Aug 2016 EP
3075354 Oct 2016 EP
3139864 Mar 2017 EP
3142603 Mar 2017 EP
3184083 Jun 2017 EP
3294220 Mar 2018 EP
3417813 Dec 2018 EP
3570779 Nov 2019 EP
2788217 Jul 2000 FR
2815844 May 2002 FR
1264471 Feb 1972 GB
1315844 May 1973 GB
2056023 Mar 1981 GB
2398245 Aug 2004 GB
1271508 Nov 1986 SU
9116041 Oct 1991 WO
9117720 Nov 1991 WO
9217118 Oct 1992 WO
9301768 Feb 1993 WO
9724080 Jul 1997 WO
9829057 Jul 1998 WO
9933414 Jul 1999 WO
9940964 Aug 1999 WO
9947075 Sep 1999 WO
0047139 Aug 2000 WO
03047468 Jun 2003 WO
03092554 Nov 2003 WO
2004030569 Apr 2004 WO
2004100652 Nov 2004 WO
2005011534 Feb 2005 WO
2005034812 Apr 2005 WO
2005087140 Sep 2005 WO
2005102015 Nov 2005 WO
2006014233 Feb 2006 WO
2006034008 Mar 2006 WO
2006085225 Aug 2006 WO
2006100034 Sep 2006 WO
2006108090 Oct 2006 WO
2006111391 Oct 2006 WO
2006138173 Dec 2006 WO
2007025028 Mar 2007 WO
2008005405 Jan 2008 WO
2008035337 Mar 2008 WO
2008125153 Oct 2008 WO
2008147964 Dec 2008 WO
2008150529 Dec 2008 WO
2009024859 Feb 2009 WO
2009026563 Feb 2009 WO
2009042196 Apr 2009 WO
2009091509 Jul 2009 WO
2009094500 Jul 2009 WO
2010005524 Jan 2010 WO
2010008549 Jan 2010 WO
2010121076 Oct 2010 WO
2011002996 Jan 2011 WO
2011081997 Jul 2011 WO
2012008459 Jan 2012 WO
2012032187 Mar 2012 WO
2012095455 Jul 2012 WO
2013005878 Jan 2013 WO
2013028387 Feb 2013 WO
2013106585 Jul 2013 WO
2014009213 Jan 2014 WO
2014018432 Jan 2014 WO
2014079291 May 2014 WO
2014145338 Sep 2014 WO
2014149865 Sep 2014 WO
2014163706 Oct 2014 WO
2014194178 Dec 2014 WO
2015004624 Jan 2015 WO
2015004625 Jan 2015 WO
2015057407 Apr 2015 WO
2015077274 May 2015 WO
2016002189 Jan 2016 WO
2016004137 Jan 2016 WO
2016016899 Feb 2016 WO
2017006510 Jan 2017 WO
2017035487 Mar 2017 WO
2018000333 Jan 2018 WO
2018213209 Nov 2018 WO
2022002054 Jan 2022 WO
2023006048 Feb 2023 WO
2023076103 May 2023 WO
2023081236 May 2023 WO
2023091769 May 2023 WO
2023096804 Jun 2023 WO
2023154250 Aug 2023 WO
2023196150 Oct 2023 WO
2023244454 Dec 2023 WO
2023244767 Dec 2023 WO
2023250114 Dec 2023 WO
2024001789 Jan 2024 WO
2024003620 Jan 2024 WO
2024007575 Jan 2024 WO
2024009540 Jan 2024 WO
2024010739 Jan 2024 WO
2024030520 Feb 2024 WO
Non-Patent Literature Citations (24)
Entry
Al Zaibag et al., “Percutaneous Balloon Valvotomy in Tricuspid Stenosis”, British Heart Journal, vol. 57, No. 1, Jan. 1987.
Al-Khaja et al., “Eleven years' experience with Carpentier-Edwards biological valves in relation to survival and complications”, European Journal of Cardio-Thoracic Surgery, vol. 3, No. 4, pp. 305-311, Jul. 1, 1989, Springer-Verlag, Berlin, Germany.
Almagor et al., “Balloon Expandable Stent Implantation in Stenotic Right Heart Valved Conduits”, Journal of the American College of Cardiology, vol. 16, No. 5, pp. 1310-1314, Nov. 15, 1990.
Andersen, et al., “Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs”, European Heart Journal, vol. 13, No. 5, pp. 704-708, May 1, 1992, The European Society of Cardiology, Oxford University Press, United Kingdom.
Andersen, H.R. “History of Percutaneous Aortic Valve Prosthesis,” Herz, vol. 34., No. 5, pp. 343-346, Aug. 2009, Urban & Vogel, Germany.
Backer, Ole De, MD, et al., “Percutaneous Transcatheter Mitral Valve Replacement—An Overview of Devices in Preclinical and Early Clinical Evaluation,” Contemporary Reviews in Interventional Cardiology, Circ Cardiovasc Interv. 2014;7:400-409, Applicant believes this may have been available as early as Jun. of 2014.
Banai, Shmeul et al., The Journal of the American College of Cardiology, “Transapical Mitral Implantation of the Tiara Bioprosthesis Pre-Clinical Results,” Feb. 2014, <http://interventions. onlinejacc.org/article. aspx?articleid=1831234>.
Benchimol et al., “Simultaneous left ventricular echocardiography and aortic blood velocity during rapid right ventricular pacing in man”, The American Journal of the Medical Sciences, vol. 273, No. 1, pp. 55-62, Jan.-Feb. 1977, Elsevier, United States.
Berreklouw, Eric, PhD, et al., “Sutureless Mitral Valve Replacement With Bioprostheses and Nitinol Attachment Rings: Feasibility in Acute Pig Experiments,” The Journal of Thoracic and Cardiovascular Surgery, vol. 142, No. 2, Aug. 2011 in 7 pages, Applicant believes this may have been available online as early as Feb. 7, 2011.
Dake et al., “Transluminal Placement of Endovascular Stent-Grafts for the Treatment of Descending Thoracic Aortic Aneurysms”, The New England Journal of Medicine, vol. 331, No. 26, pp. 1729-1734, Dec. 29, 1994.
Dotter et al., “Transluminal Treatment of Arteriosclerotic Obstruction: Description of a New Technic and a Preliminary Report of Its Application”, Circulation, vol. XXX, No. 30, pp. 654-670, Nov. 1, 1964, Lippincott Williams & Wilkins, Philadelphia, PA.
Inoune et al., “Clinical application of transvenous mitral commissurotomy by a new balloon catheter,” The Journal of Thoracic and Cardiovascular Surgery, vol. 87, No. 3, pp. 394-402, Mar. 1984, Elsevier, United States.
Kolata, Gina “Device That Opens Clogged Arteries Gets a Failing Grade in a New Study”, The New York Times, Jan. 3, 1991, pp. 1-2 [online], [retrieved on Jul. 29, 2009]. Retrieved from the Internet <URL:http://www.nytimes.com/1991/01/03/health/device-that-opens-clogged-arteries-gets-a-faili . . . .
Lawrence, Jr., et al., “Percutaneous Endovascular Graft: Experimental Evaluation”, Cardiovascular Radiology 163, pp. 357-360, May 1987.
Pavcnik et al., “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement,” Radiology, vol. 183, No. 1, pp. 151-154, Apr. 1, 1992. Elsevier, United States.
Porstmann et al., “Der Verschluß des Ductus Arteriosus Persistens Ohne Thorakotomie”, Thoraxchirurgie Vaskulare Chirurgie, Band 15, Heft 2, Stuttgart, im Apr. 1967, pp. 199-203.
Sabbah et al., “Mechanical Factors in the Degeneration of Porcine Bioprosthetic Valves: An Overview”, Journal of Cardiac Surgery, vol. 4, No. 4, pp. 302-309, Dec. 1989.
Selby et al., “Experience with New Retrieval Forceps for Foreign Body Removal in the Vascular, Urinary, and Biliary Systems”, Radiology, vol. 176, No. 2, pp. 535-538, Jul. 31, 1990, Radiological Society of North America, Oak Brook, IL.
Serruys et al., “Stenting of coronary arteries. Are we the sorcerer's apprentice?”, European Heart Journal, vol. 10, No. 9 pp. 774-782, Sep. 1, 1989, The European Society of Cardiology, Oxford University Press, United Kingdom.
Sigwart, Ulrich, “An Overview of Intravascular Stents: Old and New,” Textbook of Interventional Cardiology, Second Edition, chapter 48, pp. 803-815, © 1994, W.B. Saunders Company, Philadelphia, PA.
Uchida et al., “Modifications of Gianturco Expandable Wire Stents”, Technical Note, American Roentgen Ray Society, pp. 1185-1187, May 1988.
Urban, Philip MD, “Coronary Artery Stenting”, pp. 5-47, © 1991, ISBN: 2-88049-054-5, Editions Medecine et Hygiene, Geneva, Switzerland.
Watt et al., “Intravenous adenosine in the treatment of supraventricular rachycardia: a dose-ranging study and interaction with dipyridamole”, British Journal of Clinical Pharmacology, vol. 21, No. 2, pp. 227-230, Feb. 1986, British Pharmacological Society, London, United Kingdom.
Wheatley, David J., “Valve Prosthesis”, Rob & Smith's Operative Surgery—Cardiac Surgery, vol. 91, No. 2, pp. 415-424, Feb. 1, 1987, Butterworth Scientific, London, UK.
Related Publications (1)
Number Date Country
20230157818 A1 May 2023 US
Continuations (2)
Number Date Country
Parent 16740916 Jan 2020 US
Child 18095979 US
Parent 15526810 US
Child 16740916 US